Detalles de la búsqueda
1.
Tumor Response Predicts Survival Time of Nivolumab Monotherapy for Advanced Gastric Cancer: A Subgroup Analysis of the DELIVER Trial (JACCRO GC-08).
Oncologist
; 2024 Apr 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38581687
2.
Trifluridine/tipiracil+bevacizumab (BEV) vs. fluoropyrimidine-irinotecan+BEV as second-line therapy for metastatic colorectal cancer: a randomised noninferiority trial.
Br J Cancer
; 128(10): 1897-1905, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36871043
3.
Multicenter Retrospective Analysis of Original versus Modified FOLFIRINOX in Metastatic Pancreatic Cancer: Results of the NAPOLEON Study.
Oncology
; 101(1): 22-31, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36195058
4.
Prognostic impact of severe neutropenia in colorectal cancer patients treated with TAS-102 and bevacizumab, addressing immortal-time bias.
BMC Cancer
; 23(1): 1078, 2023 Nov 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37940878
5.
Pattern of disease progression during third-line or later chemotherapy with nivolumab associated with poor prognosis in advanced gastric cancer: a multicenter retrospective study in Japan.
Gastric Cancer
; 26(1): 132-144, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36316527
6.
Scoring model with serum albumin and CA19-9 for metastatic pancreatic cancer in second-line treatment: results from the NAPOLEON study.
Int J Clin Oncol
; 28(8): 1073-1081, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37209158
7.
Panitumumab vs Bevacizumab Added to Standard First-line Chemotherapy and Overall Survival Among Patients With RAS Wild-type, Left-Sided Metastatic Colorectal Cancer: A Randomized Clinical Trial.
JAMA
; 329(15): 1271-1282, 2023 04 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37071094
8.
Expert panel consensus recommendations on the use of circulating tumor DNA assays for patients with advanced solid tumors.
Cancer Sci
; 113(11): 3646-3656, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35876224
9.
RAD51 Expression as a Biomarker to Predict Efficacy of Preoperative Therapy and Survival for Esophageal Squamous Cell Carcinoma: A Large-cohort Observational Study (KSCC1307).
Ann Surg
; 275(4): 692-699, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32482981
10.
One-Day Versus Three-Day Dexamethasone with NK1RA for Patients Receiving Carboplatin and Moderate Emetogenic Chemotherapy: A Network Meta-analysis.
Oncologist
; 27(6): e524-e532, 2022 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35427418
11.
Prognostic nomogram for patients with unresectable pancreatic cancer treated with gemcitabine plus nab-paclitaxel or FOLFIRINOX: A post-hoc analysis of a multicenter retrospective study in Japan (NAPOLEON study).
BMC Cancer
; 22(1): 19, 2022 Jan 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34980029
12.
Gastric carcinosarcoma with FGFR2 amplification under long-term control with pazopanib: a case report and literature review.
BMC Gastroenterol
; 22(1): 360, 2022 Jul 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35902814
13.
Phase II study of S-1 and oxaliplatin as neoadjuvant chemotherapy for locally advanced adenocarcinoma of the gastric or esophagogastric junction: KSCC1601.
Gastric Cancer
; 25(1): 180-187, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34379229
14.
Real-world effectiveness of nivolumab in advanced gastric cancer: the DELIVER trial (JACCRO GC-08).
Gastric Cancer
; 25(1): 235-244, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34427838
15.
Prospective analysis of the expression status of FGFR2 and HER2 in colorectal and gastric cancer populations: DS-Screen Study.
Int J Colorectal Dis
; 37(6): 1393-1402, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35585358
16.
A multicentre retrospective study comparing site-specific treatment with empiric treatment for unfavourable subset of cancer of unknown primary site.
Jpn J Clin Oncol
; 52(12): 1416-1422, 2022 Dec 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36047806
17.
Monitoring FTD in the peripheral blood mononuclear cells of elderly patients with metastatic colorectal cancer administered FTD plus bevacizumab as first-line treatment.
Cancer Sci
; 112(6): 2436-2441, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33780084
18.
Second-line chemotherapy after early disease progression during first-line chemotherapy containing bevacizumab for patients with metastatic colorectal cancer.
BMC Cancer
; 21(1): 1159, 2021 Oct 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-34715820
19.
Association of albumin-bilirubin score in patients with colorectal cancer receiving later-line chemotherapy with regorafenib.
Int J Clin Oncol
; 26(7): 1257-1263, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33839963
20.
Safety and efficacy of S-1 plus oxaliplatin 130 mg/m2 combination therapy in patients with previously untreated HER2-negative unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: a phase II trial (KSCC1501A).
Int J Clin Oncol
; 26(2): 345-354, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33085058